Document Detail


Single injection of triamcinolone versus three repeated injections of bevacizumab for treatment of diabetic macular edema.
MedLine Citation:
PMID:  23334618     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
To compare the effect of a single intravitreal injection of triamcinolone acetonide versus three consecutive monthly intravitreal injections of bevacizumab for the treatment of diabetic macular edema (DME). Forty patients treated with a single intravitreal injection of 4 mg triamcinolone acetonide (triamcinolone group) were compared with 40 patients treated with three consecutive monthly intravitreal injections of 1.25 mg bevacizumab (bevacizumab group). The triamcinolone group showed a significant decrease in mean central retinal thickness (CRT) from 472.5 μm ± 120.35 to 374.0 μm ± 152.31 after 3 months (p < 0.001). The bevacizumab group also showed a significant reduction in CRT from 464.5 μm ± 115.3 to 370.0 μm ± 142.31 (p < 0.001). The triamcinolone group displayed an increase in best-corrected visual acuity (BCVA) following a single intravitreal triamcinolone acetonide injection from a mean of +0.70 ± 0.17 logMAR to a mean of +0.54 ± 0.38 logMAR after 3 months (p < 0.05). The bevacizumab group also showed an increase in BCVA following three injections of bevacizumab from a mean of +0.73 ± 0.28 logMAR to a mean of +0.57 ± 0.33 logMAR (p < 0.05). Statistical analysis showed no significant difference between both groups at 3 months. Our study showed that a single intravitreal injection of triamcinolone is as effective as three consecutive monthly intravitreal injections of bevacizumab for treatment of DME with regard to BCVA and CRT measured by optical coherence tomography. Despite the recent popularity of bevacizumab, three injections are no more effective than a single injection of triamcinolone for the treatment of DME.
Authors:
Mehmet Taş; Veysi Oner; Mehmet Fuat Alakuş; Fatih Mehmet Türkcü; Yalçın Işcan; Kemal Yüksel
Related Documents :
22510008 - Changes in anterior chamber parameters with the pentacam rotating scheimpflug and axial...
22652498 - Effects of rapid maxillary expansion on middle ear function: one-year follow-up.
22998438 - Isotretinoin treatment in nodulocystic acne with and without polycystic ovary syndrome:...
24258968 - Pulsed dye laser and intralesional bleomycin for the treatment of recalcitrant cutaneou...
22510008 - Changes in anterior chamber parameters with the pentacam rotating scheimpflug and axial...
19752378 - Rate of progression and functional significance of aortic root calcification after homo...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-19
Journal Detail:
Title:  International ophthalmology     Volume:  -     ISSN:  1573-2630     ISO Abbreviation:  Int Ophthalmol     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-21     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7904294     Medline TA:  Int Ophthalmol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Ophthalmology, Malatya State Hospital, Malatya, Turkey.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Vitreomacular interface in patients with familial exudative vitreoretinopathy.
Next Document:  Best Practices in Secondary Fracture Prevention: Fracture Liaison Services.